NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization125.45 mln
Float26.94 mln
Earnings Date05/29/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
-0.75
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Jyong Biotech Ltd., founded in 2002 and based in New Taipei City, Taiwan, focuses on turning plant-based compounds into approved medicines for urinary health conditions. The company is currently advancing three treatment candidates targeting benign prostate enlargement, prostate cancer, and bladder pain syndrome. Its products are being developed for patients in the United States, Europe, and Asia.
